# Ensysce Biosciences, Inc.: Form 8-K, filed Jun 5, 2025

- Company: [Ensysce Biosciences, Inc.](/companies/ensc.md) (CIK 1716947)
- Form: 8-K
- Filed: 2025-06-05
- Accepted by EDGAR: Jun 5, 2025, 17:02 ET
- Period: 2025-06-05
- Accession: 0001641172-25-013853
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1716947/000164117225013853/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1716947/000164117225013853/

## Items reported

- Item 4.01: Change of auditor
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1716947/000164117225013853/form8-k.htm

Filed Jun 5, 2025.
Source: SEC EDGAR, the filing index for accession 0001641172-25-013853. Last ingested by Listed: Nov 4, 2026, 12:47 ET. No prices; not investment advice.